125 related articles for article (PubMed ID: 32519121)
1. Anxiety and depression after diagnosis of high-risk primary cutaneous melanoma: a 4-year longitudinal study.
Beesley VL; Hughes MCB; Smithers BM; Khosrotehrani K; Malt MK; von Schuckmann LA; Green AC
J Cancer Surviv; 2020 Oct; 14(5):712-719. PubMed ID: 32519121
[TBL] [Abstract][Full Text] [Related]
2. Supportive care needs, anxiety, depression and quality of life amongst newly diagnosed patients with localised invasive cutaneous melanoma in Queensland, Australia.
Beesley VL; Smithers BM; Khosrotehrani K; Khatun M; O'Rourke P; Hughes MC; Malt MK; Zonta MJ; Bayley GJ; Barbour AP; Brown LJ; D'Arcy J; Allan CP; Green AC
Psychooncology; 2015 Jul; 24(7):763-70. PubMed ID: 25355178
[TBL] [Abstract][Full Text] [Related]
3. Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study.
Beutel ME; Fischbeck S; Binder H; Blettner M; Brähler E; Emrich K; Friedrich-Mai P; Imruck BH; Weyer V; Zeissig SR
PLoS One; 2015; 10(1):e0116440. PubMed ID: 25615573
[TBL] [Abstract][Full Text] [Related]
4. Variations in supportive care needs of patients after diagnosis of localised cutaneous melanoma: a 2-year follow-up study.
Beesley VL; Smithers BM; O'Rourke P; Janda M; Khosrotehrani K; Green AC
Support Care Cancer; 2017 Jan; 25(1):93-102. PubMed ID: 27562298
[TBL] [Abstract][Full Text] [Related]
5. Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES Registry: Prevalence, predictors, and impact on quality of life.
Mols F; Schoormans D; de Hingh I; Oerlemans S; Husson O
Cancer; 2018 Jun; 124(12):2621-2628. PubMed ID: 29624635
[TBL] [Abstract][Full Text] [Related]
6. Predictors of anxiety and depression 2 years following treatment in uveal melanoma survivors.
Brown SL; Hope-Stone L; Heimann H; Damato B; Salmon P
Psychooncology; 2018 Jul; 27(7):1727-1734. PubMed ID: 29601654
[TBL] [Abstract][Full Text] [Related]
7. Seven-year distress trajectories in uveal melanoma survivors.
Brown SL; Hope-Stone L; Cherry MG
Health Psychol; 2023 Apr; 42(4):247-256. PubMed ID: 36848060
[TBL] [Abstract][Full Text] [Related]
8. Predictors of long-term anxiety and depression in uveal melanoma survivors: A cross-lagged five-year analysis.
Brown SL; Fisher PL; Hope-Stone L; Hussain RN; Heimann H; Damato B; Cherry MG
Psychooncology; 2020 Nov; 29(11):1864-1873. PubMed ID: 32779313
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study.
Rogiers A; Leys C; De Cremer J; Awada G; Schembri A; Theuns P; De Ridder M; Neyns B
Support Care Cancer; 2020 Jul; 28(7):3267-3278. PubMed ID: 31745697
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of symptoms of anxiety and depression, and comorbid symptoms of distress in parents of childhood cancer survivors and bereaved parents five years after end of treatment or a child's death.
Wikman A; Mattsson E; von Essen L; Hovén E
Acta Oncol; 2018 Jul; 57(7):950-957. PubMed ID: 29498559
[TBL] [Abstract][Full Text] [Related]
11. A systematic review on the prevalence of symptoms of depression, anxiety and distress in long-term cancer survivors: Implications for primary care.
Brandenbarg D; Maass SWMC; Geerse OP; Stegmann ME; Handberg C; Schroevers MJ; Duijts SFA
Eur J Cancer Care (Engl); 2019 May; 28(3):e13086. PubMed ID: 31087398
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of follow-up in melanoma patients in Germany - results of a multicentre and longitudinal study.
Livingstone E; Krajewski C; Eigentler TK; Windemuth-Kieselbach C; Benson S; Elsenbruch S; Hauschild A; Rompel R; Meiss F; Mauerer A; Kähler KC; Dippel E; Möllenhoff K; Kilian K; Mohr P; Utikal J; Schadendorf D
Eur J Cancer; 2015 Mar; 51(5):653-67. PubMed ID: 25638778
[TBL] [Abstract][Full Text] [Related]
13. Psychological morbidity among Australian rural and urban support persons of haematological cancer survivors: Results of a national study.
Carey M; Sanson-Fisher R; Paul C; Bradstock K; Williamson A; Campbell HS
Psychooncology; 2017 Nov; 26(11):1952-1958. PubMed ID: 28253431
[TBL] [Abstract][Full Text] [Related]
14. The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients-Results after 1 Year.
Damude S; Hoekstra-Weebers JE; Francken AB; Ter Meulen S; Bastiaannet E; Hoekstra HJ
Ann Surg Oncol; 2016 Sep; 23(9):2762-71. PubMed ID: 27194552
[TBL] [Abstract][Full Text] [Related]
15. Beyond the fear that lingers: The interaction between fear of cancer recurrence and rumination in relation to depression and anxiety symptoms.
Liu J; Peh CX; Simard S; Griva K; Mahendran R
J Psychosom Res; 2018 Aug; 111():120-126. PubMed ID: 29935744
[TBL] [Abstract][Full Text] [Related]
16. Lived Experiences and Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma.
Mahama AN; Haller CN; Labrada J; Idiong CI; Haynes AB; Jacobs EA; Tsevat J; Pignone MP; Adamson AS
JAMA Dermatol; 2024 May; 160(5):495-501. PubMed ID: 38353983
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and predictors of the short-term trajectory of anxiety and depression in the first year after a cancer diagnosis: a population-based longitudinal study.
Boyes AW; Girgis A; D'Este CA; Zucca AC; Lecathelinais C; Carey ML
J Clin Oncol; 2013 Jul; 31(21):2724-9. PubMed ID: 23775970
[TBL] [Abstract][Full Text] [Related]
18. Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.
Smith A'; Sharpe L; Thewes B; Turner J; Gilchrist J; Fardell JE; Girgis A; Tesson S; Descallar J; Bell ML; Beith J; Butow P;
Support Care Cancer; 2018 Dec; 26(12):4207-4216. PubMed ID: 29882025
[TBL] [Abstract][Full Text] [Related]
19. Trajectories of Depression and Anxiety in Latina Breast Cancer Survivors.
Crane TE; Badger TA; Sikorskii A; Segrin C; Hsu CH; Rosenfeld AG
Oncol Nurs Forum; 2019 Mar; 46(2):217-227. PubMed ID: 30767959
[TBL] [Abstract][Full Text] [Related]
20. Predictors of quality of life in melanoma patients 4 years after diagnosis: Results of a nationwide cohort study in Germany.
Krajewski C; Benson S; Elsenbruch S; Schadendorf D; Livingstone E
J Psychosoc Oncol; 2018; 36(6):734-753. PubMed ID: 30321123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
